Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Family-based exome sequencing identifies rare coding variants in age-related macular degeneration.

Ratnapriya R, Acar İE, Geerlings MJ, Branham K, Kwong A, Saksens NTM, Pauper M, Corominas J, Kwicklis M, Zipprer D, Starostik MR, Othman M, Yashar B, Abecasis GR, Chew EY, Ferrington DA, Hoyng CB, Swaroop A, Hollander AI.

Hum Mol Genet. 2020 Apr 3. pii: ddaa057. doi: 10.1093/hmg/ddaa057. [Epub ahead of print]

PMID:
32246154
2.

Risk factors for calcification of the vertebrobasilar arteries in cardiovascular patients referred for a head CT, the SMART study.

van den Beukel TC, Lucci C, Hendrikse J, Spiering W, Koek HL, Geerlings MI, de Jong PA; UCC-SMART-Studygroup.

J Neuroradiol. 2020 Mar 10. pii: S0150-9861(20)30129-2. doi: 10.1016/j.neurad.2020.02.004. [Epub ahead of print]

PMID:
32169469
3.

Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis.

Pacifico J, Geerlings MAJ, Reijnierse EM, Phassouliotis C, Lim WK, Maier AB.

Exp Gerontol. 2020 Mar;131:110801. doi: 10.1016/j.exger.2019.110801. Epub 2019 Dec 28. Review.

4.

Smoking trajectories and risk of stroke until age of 50 years - The Northern Finland Birth Cohort 1966.

Rissanen I, Oura P, Paananen M, Miettunen J, Geerlings MI.

PLoS One. 2019 Dec 17;14(12):e0225909. doi: 10.1371/journal.pone.0225909. eCollection 2019.

5.

Intracranial Atherosclerotic Burden on 7T MRI Is Associated with Markers of Extracranial Atherosclerosis: The SMART-MR Study.

Zwartbol MHT, Geerlings MI, Ghaznawi R, Hendrikse J, van der Kolk AG; UCC-SMART Study Group.

AJNR Am J Neuroradiol. 2019 Dec;40(12):2016-2022. doi: 10.3174/ajnr.A6308. Epub 2019 Dec 5.

PMID:
31806592
6.

Risk factors of mortality in older patients with dementia in psychiatric care.

Golüke NMS, Geerlings MI, van de Vorst IE, Vaartjes IH, de Jonghe A, Bots ML, Koek HL.

Int J Geriatr Psychiatry. 2020 Feb;35(2):174-181. doi: 10.1002/gps.5232. Epub 2019 Dec 2.

7.

Risk factors for in-hospital mortality in patients with dementia.

Golüke NMS, van de Vorst IE, Vaartjes IH, Geerlings MI, de Jonghe A, Bots ML, Koek HL.

Maturitas. 2019 Nov;129:57-61. doi: 10.1016/j.maturitas.2019.08.007. Epub 2019 Aug 20.

PMID:
31547914
8.

Bedside placement of ventricular access devices under local anaesthesia in neonates with posthaemorrhagic hydrocephalus: preliminary experience.

van Lindert EJ, Liem KD, Geerlings M, Delye H.

Childs Nerv Syst. 2019 Dec;35(12):2307-2312. doi: 10.1007/s00381-019-04361-3. Epub 2019 Sep 10.

PMID:
31506779
9.

Subjective cognitive decline, brain imaging biomarkers, and cognitive functioning in patients with a history of vascular disease: the SMART-Medea study.

Blom K, Koek HL, Zwartbol MHT, van der Graaf Y, Kesseler L, Biessels GJ, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2019 Dec;84:33-40. doi: 10.1016/j.neurobiolaging.2019.07.011. Epub 2019 Jul 24.

10.

Progress update from the hippocampal subfields group.

Olsen RK, Carr VA, Daugherty AM, La Joie R, Amaral RSC, Amunts K, Augustinack JC, Bakker A, Bender AR, Berron D, Boccardi M, Bocchetta M, Burggren AC, Chakravarty MM, Chételat G, de Flores R, DeKraker J, Ding SL, Geerlings MI, Huang Y, Insausti R, Johnson EG, Kanel P, Kedo O, Kennedy KM, Keresztes A, Lee JK, Lindenberger U, Mueller SG, Mulligan EM, Ofen N, Palombo DJ, Pasquini L, Pluta J, Raz N, Rodrigue KM, Schlichting ML, Lee Shing Y, Stark CEL, Steve TA, Suthana NA, Wang L, Werkle-Bergner M, Yushkevich PA, Yu Q, Wisse LEM; Hippocampal Subfields Group.

Alzheimers Dement (Amst). 2019 Jun 13;11:439-449. doi: 10.1016/j.dadm.2019.04.001. eCollection 2019 Dec.

11.

Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.

Witlox L, Schagen SB, de Ruiter MB, Geerlings MI, Peeters PHM, Koevoets EW, van der Wall E, Stuiver M, Sonke G, Velthuis MJ, Palen JAMV, Jobsen JJ, May AM, Monninkhof EM.

BMJ Open. 2019 Jun 20;9(6):e028117. doi: 10.1136/bmjopen-2018-028117.

12.

An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Seda M, Geerlings M, Lim P, Jeyabalan-Srikaran J, Cichon AC, Scambler PJ, Beales PL, Hernandez-Hernandez V, Stoker AW, Jenkins D.

Mol Syndromol. 2019 Feb;10(1-2):98-114. doi: 10.1159/000491567. Epub 2018 Jul 21.

13.

Macular Dystrophy and Cone-Rod Dystrophy Caused by Mutations in the RP1 Gene: Extending the RP1 Disease Spectrum.

Verbakel SK, van Huet RAC, den Hollander AI, Geerlings MJ, Kersten E, Klevering BJ, Klaver CCW, Plomp AS, Wesseling NL, Bergen AAB, Nikopoulos K, Rivolta C, Ikeda Y, Sonoda KH, Wada Y, Boon CJF, Nakazawa T, Hoyng CB, Nishiguchi KM.

Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1192-1203. doi: 10.1167/iovs.18-26084.

PMID:
30913292
14.

Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer's disease: A 7 Tesla MRI study.

Bouvy WH, van Veluw SJ, Kuijf HJ, Zwanenburg JJ, Kappelle JL, Luijten PR, Koek HL, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study Group.

J Cereb Blood Flow Metab. 2020 Apr;40(4):739-746. doi: 10.1177/0271678X19838087. Epub 2019 Mar 19.

15.

Kidney Function and the Risk of Stroke and Dementia: The Rotterdam Study.

Koop-Nieuwelink C, Sedaghat S, Mutlu U, Licher S, Franco OH, Ikram MA, Geerlings MI, Ikram MK, Bos D.

J Alzheimers Dis. 2019;67(3):821-826. doi: 10.3233/JAD-181086.

PMID:
30664508
16.

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.

Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AV, Jian X, Malik R, Traylor M, Pulit SL, Amouyel P, Mazoyer B, Zhu YC, Kaffashian S, Schilling S, Beecham GW, Montine TJ, Schellenberg GD, Kjartansson O, Guðnason V, Knopman DS, Griswold ME, Windham BG, Gottesman RF, Mosley TH, Schmidt R, Saba Y, Schmidt H, Takeuchi F, Yamaguchi S, Nabika T, Kato N, Rajan KB, Aggarwal NT, De Jager PL, Evans DA, Psaty BM, Rotter JI, Rice K, Lopez OL, Liao J, Chen C, Cheng CY, Wong TY, Ikram MK, van der Lee SJ, Amin N, Chouraki V, DeStefano AL, Aparicio HJ, Romero JR, Maillard P, DeCarli C, Wardlaw JM, Hernández MDCV, Luciano M, Liewald D, Deary IJ, Starr JM, Bastin ME, Muñoz Maniega S, Slagboom PE, Beekman M, Deelen J, Uh HW, Lemmens R, Brodaty H, Wright MJ, Ames D, Boncoraglio GB, Hopewell JC, Beecham AH, Blanton SH, Wright CB, Sacco RL, Wen W, Thalamuthu A, Armstrong NJ, Chong E, Schofield PR, Kwok JB, van der Grond J, Stott DJ, Ford I, Jukema JW, Vernooij MW, Hofman A, Uitterlinden AG, van der Lugt A, Wittfeld K, Grabe HJ, Hosten N, von Sarnowski B, Völker U, Levi C, Jimenez-Conde J, Sharma P, Sudlow CLM, Rosand J, Woo D, Cole JW, Meschia JF, Slowik A, Thijs V, Lindgren A, Melander O, Grewal RP, Rundek T, Rexrode K, Rothwell PM, Arnett DK, Jern C, Johnson JA, Benavente OR, Wasssertheil-Smoller S, Lee JM, Wong Q, Mitchell BD, Rich SS, McArdle PF, Geerlings MI, van der Graaf Y, de Bakker PIW, Asselbergs FW, Srikanth V, Thomson R, McWhirter R, Moran C, Callisaya M, Phan T, Rutten-Jacobs LCA, Bevan S, Tzourio C, Mather KA, Sachdev PS, van Duijn CM, Worrall BB, Dichgans M, Kittner SJ, Markus HS, Ikram MA, Fornage M, Launer LJ, Seshadri S, Longstreth WT Jr, Debette S; Stroke Genetics Network (SiGN), the International Stroke Genetics Consortium (ISGC), METASTROKE, Alzheimer's Disease Genetics Consortium (ADGC), and the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Neurology. 2019 Jan 16. pii: 10.1212/WNL.0000000000006851. doi: 10.1212/WNL.0000000000006851. [Epub ahead of print]

17.

Intracranial Vessel Wall Lesions on 7T MRI (Magnetic Resonance Imaging).

Zwartbol MHT, van der Kolk AG, Ghaznawi R, van der Graaf Y, Hendrikse J, Geerlings MI; SMART Study Group.

Stroke. 2019 Jan;50(1):88-94. doi: 10.1161/STROKEAHA.118.022509.

PMID:
30582831
18.

MRI phenotypes of the brain are related to future stroke and mortality in patients with manifest arterial disease: The SMART-MR study.

Jaarsma-Coes MG, Ghaznawi R, Hendrikse J, Slump C, Witkamp TD, van der Graaf Y, Geerlings MI, de Bresser J; Second Manifestations of ARTerial disease (SMART) Study group.

J Cereb Blood Flow Metab. 2020 Feb;40(2):354-364. doi: 10.1177/0271678X18818918. Epub 2018 Dec 14.

19.

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age-related macular degeneration.

Kersten E, Geerlings MJ, Pauper M, Corominas J, Bakker B, Altay L, Fauser S, de Jong EK, Hoyng CB, den Hollander AI.

Clin Genet. 2018 Dec;94(6):569-574. doi: 10.1111/cge.13447. Epub 2018 Oct 15.

20.

The association between lacunes and white matter hyperintensity features on MRI: The SMART-MR study.

Ghaznawi R, Geerlings MI, Jaarsma-Coes MG, Zwartbol MH, Kuijf HJ, van der Graaf Y, Witkamp TD, Hendrikse J, de Bresser J.

J Cereb Blood Flow Metab. 2019 Dec;39(12):2486-2496. doi: 10.1177/0271678X18800463. Epub 2018 Sep 11.

21.

Hippocampal sulcal cavities: prevalence, risk factors and association with cognitive performance. The SMART-Medea study and PREDICT-MR study.

Blom K, Koek HL, van der Graaf Y, Zwartbol MHT, Wisse LEM, Hendrikse J, Biessels GJ, Geerlings MI; SMART Study Group.

Brain Imaging Behav. 2019 Aug;13(4):1093-1102. doi: 10.1007/s11682-018-9916-y.

22.

Hippocampal Calcifications: Risk Factors and Association with Cognitive Function.

de Brouwer EJM, Kockelkoren R, Claus JJ, de Jonghe A, Geerlings MI, Jongsma TEF, Mali WPTM, Hendrikse J, de Jong PA, Koek HL.

Radiology. 2018 Sep;288(3):815-820. doi: 10.1148/radiol.2018172588. Epub 2018 Jun 12.

PMID:
29893650
23.

Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.

Geerlings MJ, Volokhina EB, de Jong EK, van de Kar N, Pauper M, Hoyng CB, van den Heuvel LP, den Hollander AI.

Clin Genet. 2018 Oct;94(3-4):330-338. doi: 10.1111/cge.13392. Epub 2018 Jul 10.

24.

Functional analyses of rare genetic variants in complement component C9 identified in patients with age-related macular degeneration.

Kremlitzka M, Geerlings MJ, de Jong S, Bakker B, Nilsson SC, Fauser S, Hoyng CB, de Jong EK, den Hollander AI, Blom AM.

Hum Mol Genet. 2018 Aug 1;27(15):2678-2688. doi: 10.1093/hmg/ddy178.

PMID:
29767720
25.

Whole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's Membrane.

Corominas J, Colijn JM, Geerlings MJ, Pauper M, Bakker B, Amin N, Lores Motta L, Kersten E, Garanto A, Verlouw JAM, van Rooij JGJ, Kraaij R, de Jong PTVM, Hofman A, Vingerling JR, Schick T, Fauser S, de Jong EK, van Duijn CM, Hoyng CB, Klaver CCW, den Hollander AI.

Ophthalmology. 2018 Sep;125(9):1433-1443. doi: 10.1016/j.ophtha.2018.03.040. Epub 2018 Apr 26.

26.

White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.

van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP.

J Alzheimers Dis. 2018;63(2):515-527. doi: 10.3233/JAD-170573. Review.

PMID:
29630548
27.

Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?

Xie L, Shinohara RT, Ittyerah R, Kuijf HJ, Pluta JB, Blom K, Kooistra M, Reijmer YD, Koek HL, Zwanenburg JJM, Wang H, Luijten PR, Geerlings MI, Das SR, Biessels GJ, Wolk DA, Yushkevich PA, Wisse LEM.

J Alzheimers Dis. 2018;63(1):217-225. doi: 10.3233/JAD-170932.

28.

Geographic distribution of rare variants associated with age-related macular degeneration.

Geerlings MJ, Kersten E, Groenewoud JMM, Fritsche LG, Hoyng CB, de Jong EK, den Hollander AI.

Mol Vis. 2018 Jan 27;24:75-82. eCollection 2018.

29.

Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.

Lorés-Motta L, Paun CC, Corominas J, Pauper M, Geerlings MJ, Altay L, Schick T, Daha MR, Fauser S, Hoyng CB, den Hollander AI, de Jong EK.

Ophthalmology. 2018 Jul;125(7):1064-1074. doi: 10.1016/j.ophtha.2017.12.023. Epub 2018 Feb 2.

30.

Phenotype Characteristics of Patients With Age-Related Macular Degeneration Carrying a Rare Variant in the Complement Factor H Gene.

Kersten E, Geerlings MJ, den Hollander AI, de Jong EK, Fauser S, Peto T, Hoyng CB.

JAMA Ophthalmol. 2017 Oct 1;135(10):1037-1044. doi: 10.1001/jamaophthalmol.2017.3195.

31.

Reply to: Late-Life Depression, Cortisol, and the Hippocampus: On the Need to Consider Depressive, Hippocampal, and Pharmacological Complexities.

Geerlings MI, Gerritsen L.

Biol Psychiatry. 2018 Jan 1;83(1):e25. doi: 10.1016/j.biopsych.2017.07.002. Epub 2017 Jul 12. No abstract available.

PMID:
28838558
32.

Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum.

der Strate BV, Longdin R, Geerlings M, Bachmayer N, Cavallin M, Litwin V, Patel M, Passe-Coutrin W, Schoelch C, Companjen A, Fjording MS.

Bioanalysis. 2017 Aug;9(16):1253-1264. doi: 10.4155/bio-2017-0093. Epub 2017 Aug 2.

33.

Physical Activity and Characteristics of the Carotid Artery Wall in High-Risk Patients-The SMART (Second Manifestations of Arterial Disease) Study.

Boss HM, van der Graaf Y, Visseren FLJ, Van den Berg-Vos RM, Bots ML, de Borst GJ, Cramer MJ, Kappelle LJ, Geerlings MI; SMART Study Group.

J Am Heart Assoc. 2017 Jul 23;6(7). pii: e005143. doi: 10.1161/JAHA.116.005143.

34.

Detection and characterization of small infarcts in the caudate nucleus on 7 Tesla MRI: The SMART-MR study.

Ghaznawi R, de Bresser J, van der Graaf Y, Zwartbol MH, Witkamp TD, Geerlings MI, Hendrikse J; SMART Study Group *.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1609-1617. doi: 10.1177/0271678X17705974. Epub 2017 Apr 24.

35.

Cardiorespiratory fitness, cognition and brain structure after TIA or minor ischemic stroke.

Boss HM, Van Schaik SM, Witkamp TD, Geerlings MI, Weinstein HC, Van den Berg-Vos RM.

Int J Stroke. 2017 Oct;12(7):724-731. doi: 10.1177/1747493017702666. Epub 2017 Apr 6.

PMID:
28382852
36.

Late-Life Depression, Hippocampal Volumes, and Hypothalamic-Pituitary-Adrenal Axis Regulation: A Systematic Review and Meta-analysis.

Geerlings MI, Gerritsen L.

Biol Psychiatry. 2017 Sep 1;82(5):339-350. doi: 10.1016/j.biopsych.2016.12.032. Epub 2017 Jan 27. Review.

PMID:
28318491
37.

Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep White Matter and Basal Ganglia: The Second Manifestations of ARTerial Disease-Magnetic Resonance Study.

Kloppenborg RP, Nederkoorn PJ, Grool AM, De Cocker LJ, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Cerebrovasc Dis. 2017;43(3-4):161-168. doi: 10.1159/000454782. Epub 2017 Jan 31.

38.

Cardiorespiratory Fitness after Transient Ischemic Attack and Minor Ischemic Stroke: Baseline Data of the MoveIT Study.

Boss HM, Deijle IA, Van Schaik SM, de Melker EC, van den Berg BTJ, Weinstein HC, Geerlings MI, Kappelle LJ, Van den Berg-Vos RM.

J Stroke Cerebrovasc Dis. 2017 May;26(5):1114-1120. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.029. Epub 2017 Jan 12.

PMID:
28089564
39.

The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.

Geerlings MJ, de Jong EK, den Hollander AI.

Mol Immunol. 2017 Apr;84:65-76. doi: 10.1016/j.molimm.2016.11.016. Epub 2016 Dec 6. Review.

40.

The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration.

Geerlings MJ, Kremlitzka M, Bakker B, Nilsson SC, Saksens NT, Lechanteur YT, Pauper M, Corominas J, Fauser S, Hoyng CB, Blom AM, de Jong EK, den Hollander AI.

JAMA Ophthalmol. 2017 Jan 1;135(1):39-46. doi: 10.1001/jamaophthalmol.2016.4604.

PMID:
27918759
41.

Hippocampal volume and the course of depressive symptoms over eight years of follow-up.

Buddeke J, Kooistra M, Zuithoff NP, Gerritsen L, Biessels GJ, van der Graaf Y, Geerlings MI; SMART Study Group.

Acta Psychiatr Scand. 2017 Jan;135(1):78-86. doi: 10.1111/acps.12662. Epub 2016 Nov 1.

PMID:
27800603
42.

Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1653-1667. Epub 2016 Aug 5. Review.

43.

The natural course of elevated levels of depressive symptoms in patients with vascular disease over eight years of follow-up. The SMART-Medea study.

Kooistra M, van der Graaf Y, Grool AM, Zuithoff NP, Jan Biessels G, Geerlings MI; SMART-MR Study Group.

J Affect Disord. 2016 Sep 15;202:95-101. doi: 10.1016/j.jad.2016.05.050. Epub 2016 May 24.

PMID:
27259081
44.

Perivascular spaces on 7 Tesla brain MRI are related to markers of small vessel disease but not to age or cardiovascular risk factors.

Bouvy WH, Zwanenburg JJM, Reinink R, Wisse LEM, Luijten PR, Kappelle LJ, Geerlings MI, Biessels GJ; Utrecht Vascular Cognitive Impairment (VCI) Study group.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1708-1717. Epub 2016 May 6.

45.

Suicidality in primary care patients who present with sadness and anhedonia: a prospective European study.

Moreno-Küstner B, Jones R, Švab I, Maaroos H, Xavier M, Geerlings M, Torres-González F, Nazareth I, Motrico-Martínez E, Montón-Franco C, Gil-de-Gómez MJ, Sánchez-Celaya M, Díaz-Barreiros MÁ, Vicens-Caldentey C, King M.

BMC Psychiatry. 2016 Apr 6;16:94. doi: 10.1186/s12888-016-0775-z.

46.

Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration.

Duvvari MR, van de Ven JP, Geerlings MJ, Saksens NT, Bakker B, Henkes A, Neveling K, del Rosario M, Westra D, van den Heuvel LP, Schick T, Fauser S, Boon CJ, Hoyng CB, de Jong EK, den Hollander AI.

PLoS One. 2016 Mar 23;11(3):e0152047. doi: 10.1371/journal.pone.0152047. eCollection 2016.

47.

Automated Hippocampal Subfield Segmentation at 7T MRI.

Wisse LE, Kuijf HJ, Honingh AM, Wang H, Pluta JB, Das SR, Wolk DA, Zwanenburg JJ, Yushkevich PA, Geerlings MI.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1050-7. doi: 10.3174/ajnr.A4659. Epub 2016 Feb 4.

48.

Correction. SMART Study Group. Cerebellar cortical infarct cavities: correlation with risk factors and MRI markers of cerebrovascular disease.

De Cocker LJ, Kloppenborg RP, van der Graaf Y, Luijten PR, Hendrikse J, Geerlings MI.

Stroke. 2016 Feb;47(2):e38. doi: 10.1161/STR.0000000000000094. No abstract available.

PMID:
26811333
49.

The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease.

Koopal C, Geerlings MI, Muller M, de Borst GJ, Algra A, van der Graaf Y, Visseren FL; SMART Study Group.

Atherosclerosis. 2016 Mar;246:187-92. doi: 10.1016/j.atherosclerosis.2016.01.009. Epub 2016 Jan 11.

PMID:
26800308
50.

Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration.

Saksens NT, Geerlings MJ, Bakker B, Schick T, Daha MR, Fauser S, Boon CJ, de Jong EK, Hoyng CB, den Hollander AI.

JAMA Ophthalmol. 2016 Mar;134(3):287-93. doi: 10.1001/jamaophthalmol.2015.5592.

PMID:
26767664

Supplemental Content

Loading ...
Support Center